Genetic polymorphisms-137 (G > C) (rs187238) and-607 (C > A) (rs1946518) and serum level of interleukin 18 in Fars ethnic groups with metabolic syndrome in Northern Iran
| dc.contributor.author | Aghajani, Roja | |
| dc.contributor.author | Saeidi, Mohsen | |
| dc.contributor.author | Amiriani, Taghi | |
| dc.contributor.author | Marjani, Majid | |
| dc.contributor.author | Amiriani, Amir Hossein | |
| dc.contributor.author | Tabib, Atefeh Akhavan | |
| dc.contributor.author | Marjani, Abdoljalal | |
| dc.date.accessioned | 2026-02-06T18:47:18Z | |
| dc.date.issued | 2022 | |
| dc.department | Doğu Akdeniz Üniversitesi | |
| dc.description.abstract | Introduction:We aimed to determine the genetic polymorphisms and serum level of interleukin 18 in Fars ethnic groups. Material and methods:226 Fars ethnic groups were participated. The ATP III criteria were used to assess MS components. The SNPs of the IL-18 gene were determined with ARMS-PCR. Results:The GG, GC, and CC genotypes of -137 were 50%, 40%, and 10%. The CC, CA, and AA genotypes of -607 were 45%, 37%, and 18%. The GG, GC, and CC genotypes of -137 were 44.20%, 43.40%, and 12.40%, and were 55.75%, 36.28%, and 7.97% in subjects with and without MS, respectively. The CC, CA, and AA genotypes of -607 were 48.70%, 37.20%, and 14.20% and were 41.60%, 37.20%, and 21.20% in both groups, respectively. Conclusion:IL-18 gene may different in specific populations, different ethnic groups and geographic regions. The IL-18 polymorphisms might not be used as a marker of metabolic syndrome. | |
| dc.description.sponsorship | Golestan University of Medical Science | |
| dc.description.sponsorship | This work has been supported by the Research Deputy of the Golestan University of Medical Science. | |
| dc.identifier.doi | 10.1080/13813455.2020.1784954 | |
| dc.identifier.endpage | 1602 | |
| dc.identifier.issn | 1381-3455 | |
| dc.identifier.issn | 1744-4160 | |
| dc.identifier.issue | 6 | |
| dc.identifier.orcid | 0000-0002-0399-6160 | |
| dc.identifier.pmid | 32633568 | |
| dc.identifier.scopus | 2-s2.0-85087608469 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 1596 | |
| dc.identifier.uri | https://doi.org/10.1080/13813455.2020.1784954 | |
| dc.identifier.uri | https://hdl.handle.net/11129/14327 | |
| dc.identifier.volume | 128 | |
| dc.identifier.wos | WOS:000546894200001 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | PubMed | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Taylor & Francis Ltd | |
| dc.relation.ispartof | Archives of Physiology and Biochemistry | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260204 | |
| dc.subject | Genetic polymorphism | |
| dc.subject | interleukin 18 | |
| dc.subject | Fars ethnic | |
| dc.subject | metabolic syndrome | |
| dc.subject | Iran | |
| dc.title | Genetic polymorphisms-137 (G > C) (rs187238) and-607 (C > A) (rs1946518) and serum level of interleukin 18 in Fars ethnic groups with metabolic syndrome in Northern Iran | |
| dc.type | Article |










